KR102839034B1 - 약물-불특정 환자별 투여 요법을 위한 시스템 및 방법 - Google Patents

약물-불특정 환자별 투여 요법을 위한 시스템 및 방법

Info

Publication number
KR102839034B1
KR102839034B1 KR1020217032413A KR20217032413A KR102839034B1 KR 102839034 B1 KR102839034 B1 KR 102839034B1 KR 1020217032413 A KR1020217032413 A KR 1020217032413A KR 20217032413 A KR20217032413 A KR 20217032413A KR 102839034 B1 KR102839034 B1 KR 102839034B1
Authority
KR
South Korea
Prior art keywords
therapeutically active
patient
drug
delete delete
data
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020217032413A
Other languages
English (en)
Korean (ko)
Other versions
KR20220002884A (ko
Inventor
다이앤 몰드
Original Assignee
다이앤 몰드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2019/028750 external-priority patent/WO2019209845A1/en
Application filed by 다이앤 몰드 filed Critical 다이앤 몰드
Publication of KR20220002884A publication Critical patent/KR20220002884A/ko
Application granted granted Critical
Publication of KR102839034B1 publication Critical patent/KR102839034B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Biomedical Technology (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1020217032413A 2019-03-08 2020-03-09 약물-불특정 환자별 투여 요법을 위한 시스템 및 방법 Active KR102839034B1 (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962815825P 2019-03-08 2019-03-08
US62/815,825 2019-03-08
USPCT/US2019/028750 2019-04-23
US16/391,950 2019-04-23
PCT/US2019/028750 WO2019209845A1 (en) 2018-04-23 2019-04-23 Systems and methods for modifying adaptive dosing regimens
US16/391,950 US20190326002A1 (en) 2018-04-23 2019-04-23 Systems and methods for modifying adaptive dosing regimens
PCT/US2020/021742 WO2020185699A1 (en) 2019-03-08 2020-03-09 Systems and methods for drug-agnostic patient-specific dosing regimens

Publications (2)

Publication Number Publication Date
KR20220002884A KR20220002884A (ko) 2022-01-07
KR102839034B1 true KR102839034B1 (ko) 2025-07-28

Family

ID=72426742

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217032413A Active KR102839034B1 (ko) 2019-03-08 2020-03-09 약물-불특정 환자별 투여 요법을 위한 시스템 및 방법

Country Status (8)

Country Link
EP (1) EP3935639A1 (https=)
JP (2) JP7618239B2 (https=)
KR (1) KR102839034B1 (https=)
AU (2) AU2020239014A1 (https=)
CA (1) CA3132823A1 (https=)
IL (1) IL286145A (https=)
SG (1) SG11202109704UA (https=)
WO (1) WO2020185699A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12064664B2 (en) 2020-11-10 2024-08-20 Willowview Consulting, Llc Method and system for dynamically transforming user health and exercise-related data into visual, audio, textual, and physical data representations
US20220199266A1 (en) * 2020-12-10 2022-06-23 DataRobot, Inc. Systems and methods for using machine learning with epidemiological modeling
CN113643785B (zh) * 2021-07-22 2023-09-01 海南大学 基于dikw图谱的疫苗接种浓度确认方法
CN114765076A (zh) * 2022-04-18 2022-07-19 柳州市妇幼保健院 新生儿个体化氟康唑给药量计算方法及给药方案推荐系统
KR102834065B1 (ko) * 2022-09-22 2025-07-16 서울대학교산학협력단 약동학적 변화량 예측 장치 및 방법
CN116453669B (zh) * 2023-06-14 2023-08-25 武汉大学中南医院 一种基于大数据的护理预测方法及装置
WO2025006459A1 (en) * 2023-06-29 2025-01-02 Prxcision, Inc. Machine learning for real-time decision support
CN118016237A (zh) * 2024-01-22 2024-05-10 南栖仙策(南京)高新技术有限公司 给药剂量确定方法、装置、电子设备及存储介质
CN120448609B (zh) * 2025-07-11 2025-09-16 上海斯丹姆医药开发有限责任公司 一种流感疫苗临床试验中的数据可视化方法及系统

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010532044A (ja) 2007-06-27 2010-09-30 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト 患者生理学のモデル化に基づく各患者に固有の治療法を作成するためのシステムおよび方法
JP2013516680A (ja) 2010-01-04 2013-05-13 メイオウ ファウンデイション フォア メディカルエジュケイション アンド リサーチ 赤血球生成刺激剤（ｅｓａ）の投薬量決定
JP2013524355A (ja) 2010-04-07 2013-06-17 ノヴァディスカバリー 処置成果を予測するためのコンピュータベースシステム
JP2016500866A (ja) 2012-10-05 2016-01-14 ベイシエント エルエルシー 数学モデルの関数として患者特有の投与を提供するためのシステムおよび方法
US20160300037A1 (en) 2015-04-09 2016-10-13 Diane R. MOULD Systems and methods for patient-specific dosing

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1227302A (en) * 2000-09-15 2002-03-26 Virco Nv System and method for optimizing drug therapy for the treatment of diseases

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010532044A (ja) 2007-06-27 2010-09-30 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト 患者生理学のモデル化に基づく各患者に固有の治療法を作成するためのシステムおよび方法
JP2013516680A (ja) 2010-01-04 2013-05-13 メイオウ ファウンデイション フォア メディカルエジュケイション アンド リサーチ 赤血球生成刺激剤（ｅｓａ）の投薬量決定
JP2013524355A (ja) 2010-04-07 2013-06-17 ノヴァディスカバリー 処置成果を予測するためのコンピュータベースシステム
JP2016500866A (ja) 2012-10-05 2016-01-14 ベイシエント エルエルシー 数学モデルの関数として患者特有の投与を提供するためのシステムおよび方法
US20160300037A1 (en) 2015-04-09 2016-10-13 Diane R. MOULD Systems and methods for patient-specific dosing

Also Published As

Publication number Publication date
SG11202109704UA (en) 2021-10-28
WO2020185699A1 (en) 2020-09-17
CA3132823A1 (en) 2020-09-17
JP7618239B2 (ja) 2025-01-21
KR20220002884A (ko) 2022-01-07
JP2022524083A (ja) 2022-04-27
IL286145A (en) 2021-10-31
JP2025020335A (ja) 2025-02-12
AU2020239014A1 (en) 2021-10-07
AU2025275175A1 (en) 2026-01-15
EP3935639A1 (en) 2022-01-12

Similar Documents

Publication Publication Date Title
US20240371491A1 (en) Systems and methods for drug-agnostic patient-specific dosing regimens
KR102839034B1 (ko) 약물-불특정 환자별 투여 요법을 위한 시스템 및 방법
KR102870157B1 (ko) 적응성 투여 요법의 수정 시스템 및 방법
US11734593B2 (en) Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data
US20230187067A1 (en) Use of clinical parameters for the prediction of sirs
Weymann et al. Matching methods in precision oncology: an introduction and illustrative example
Al Faysal et al. An explainable machine learning framework for predicting the risk of buprenorphine treatment discontinuation for opioid use disorder among commercially insured individuals
WO2011156587A2 (en) Methods and systems for anticoagulation risk-benefit evaluations
US20220383991A1 (en) Systems and methods for monoclonal antibody nomograms
Liu et al. An easy and quick risk-stratified early forewarning model for septic shock in the intensive care unit: development, validation, and interpretation study
Alvares et al. A Bayesian Joint Model of Multiple Nonlinear Longitudinal and Competing Risks Outcomes for Dynamic Prediction in Multiple Myeloma: Joint Estimation and Corrected Two‐Stage Approaches
Tillman et al. A real-time prognostic model for venous thromboembolic events among hospitalized adults
Vigueras et al. A PopPBPK-RL approach for precision dosing of benazepril in renal impaired patients
Chaiben et al. Pharmacokinetic Model Selection for Personalized Infliximab Dosing in IBD
Birck et al. Evaluating Brazil’s national administrative claims data for real-world pharmacoepidemiologic studies: Trends in rheumatoid arthritis using DATASUS (2010–2020)
Caceres Guido et al. Evaluation of Predictive Pharmacokinetic Models to Optimize Infliximab Therapy in Pediatric Inflammatory Bowel Disease: PC Guido et al.
WO2024097993A1 (en) Machine learning-based risk stratification and management of non-alcoholic fatty liver disease
Curtis et al. Predicting low disease activity and remission using early treatment response to anti-TNF therapy in patients with rheumatoid arthritis: Exploratory analyses from the TEMPO trial

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

F11 Ip right granted following substantive examination

Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

U12 Designation fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

Q13 Ip right document published

Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE)